Suppr超能文献

微小RNA的差异表达在内脏利什曼病感染期间调节T细胞分化和可塑性。

Differential Expression of miRNA Regulates T Cell Differentiation and Plasticity During Visceral Leishmaniasis Infection.

作者信息

Pandey Rajan Kumar, Sundar Shyam, Prajapati Vijay Kumar

机构信息

Department of Biochemistry, School of Life Sciences, Central University of Rajasthan Kishangarh, India.

Department of Medicine, Institute of Medical Sciences, Banaras Hindu University Varanasi, India.

出版信息

Front Microbiol. 2016 Feb 25;7:206. doi: 10.3389/fmicb.2016.00206. eCollection 2016.

Abstract

Visceral leishmaniasis (VL) is a tropical neglected disease caused by Leishmania donovani, results in significant mortality in the Indian subcontinent. The plasticity of T cell proliferation and differentiation depends on microRNA mediated gene regulation which leads Th1/Th2 or Th17/Treg type of immune response during human VL. This study depicts the identification of target immune signaling molecule and transcription factors, which play a role in T-cell proliferation and differentiation followed by the identification of miRNA controlling their gene expression using three web servers' viz., TargetScan, miRPath and miRDB. This study provides the bioinformatics evidences that seed region present in the miRNAs miR-29-b, miR-29a, have the putative binding site in the 3'-untranslated region (UTR) of TBX21 transcription factor of CD4(+) T helper (Th1), which may suppress the Th1 specific protective immune response. Development of Th2 type specific immune response can be suppressed by binding of miR-135 and miR-126 miRNAs over the 3'-UTR region of GATA-3 transcription factor of Th2 specific CD4(+) T helper cells. MiRNA identified against Th2/Treg immune cells are important and their over expression or administration can be used for developing the Th1/Th17 type of protective immune response during VL infection. This study indicates that miRNAs have the capacity to regulate immune signaling, cytokine production and immune cell migration to control the VL infection in human. This observation warrants further investigation for the development of miRNA based therapy controlling T cell differentiation in human VL.

摘要

内脏利什曼病(VL)是一种由杜氏利什曼原虫引起的热带被忽视疾病,在印度次大陆导致显著的死亡率。T细胞增殖和分化的可塑性取决于微小RNA介导的基因调控,这在人类VL期间导致Th1/Th2或Th17/Treg类型的免疫反应。本研究描述了对靶免疫信号分子和转录因子的鉴定,它们在T细胞增殖和分化中发挥作用,随后使用三个网络服务器即TargetScan、miRPath和miRDB鉴定控制其基因表达的微小RNA。本研究提供了生物信息学证据,即微小RNA miR-29-b、miR-29a中的种子区域在CD4(+)辅助性T细胞(Th1)的TBX21转录因子的3'-非翻译区(UTR)中具有假定的结合位点,这可能抑制Th1特异性保护性免疫反应。Th2型特异性免疫反应的发展可通过miR-135和miR-126微小RNA在Th2特异性CD4(+)辅助性T细胞的GATA-3转录因子的3'-UTR区域上的结合来抑制。针对Th2/Treg免疫细胞鉴定出的微小RNA很重要,它们的过表达或施用可用于在VL感染期间产生Th1/Th17型保护性免疫反应。本研究表明,微小RNA有能力调节免疫信号、细胞因子产生和免疫细胞迁移,以控制人类的VL感染。这一观察结果值得进一步研究,以开发基于微小RNA的疗法来控制人类VL中的T细胞分化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2ac/4766295/fdbe46f2a888/fmicb-07-00206-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验